5-(4-Chlorobenzenesulfonyl)-2-methyl-4-phenylpyrimidine

Catalog No. :
ACJYUN561
CAS No. :
339108-35-9
Molecular Formula :
C17H13ClN2O2S
Molecular Weight :
344.82

IUPAC Name:5-((4-chlorophenyl)sulfonyl)-2-methyl-4-phenylpyrimidine

5-(4-Chlorobenzenesulfonyl)-2-methyl-4-phenylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(4-Chlorobenzenesulfonyl)-2-methyl-4-phenylpyrimidine
IUPAC Name5-((4-chlorophenyl)sulfonyl)-2-methyl-4-phenylpyrimidine
MDL No.MFCD00202601
Molecular FormulaC17H13ClN2O2S
Molecular Weight344.82
SMILESCC1=NC=C(S(=O)(C2=CC=C(Cl)C=C2)=O)C(C3=CC=CC=C3)=N1
InChI KeyRQWXMGPRMFCEPK-UHFFFAOYSA-N
Synonym5-[(4-CHLOROPHENYL)SULFONYL]-2-METHYL-4-PHENYLPYRIMIDINE;4-CHLOROPHENYL 2-METHYL-4-PHENYL-5-PYRIMIDINYL SULFONE;5-(4-chlorobenzenesulfonyl)-2-methyl-4-phenylpyrimidine;Pyrimidine, 5-[(4-chlorophenyl)sulfonyl]-2-methyl-4-phenyl-
CAS No.339108-35-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJYUN561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6 In Stock
  4. Then
  5. ACJYUN561 route product structure diagram
    ACJYUN561339108-35-9
Inquiry

2. ACJYUN561 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAXVQ506 route compound structure diagram
    ACAXVQ506100-03-8 In Stock
  4. Then
  5. ACJYUN561 route product structure diagram
    ACJYUN561339108-35-9
Inquiry

Comments (0)